INS and fatty liver disease: Remarkably, while the glucoregulatory function of the novel adipokine is shared with insulin, ISM1 also neutralizes lipid accumulation in the liver by inhibiting de novo lipogenesis, promoting protein synthesis and preventing hepatic steatosis in a diet-induced fatty liver mouse model.